UNRIF yields 217.86% · MRK yields 2.76%● Live data
📍 UNRIF pulled ahead of the other in Year 1
Combined, UNRIF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UNRIF + MRK for your $10,000?
United Company RUSAL, International Public Joint-Stock Company produces and sells aluminum and related products. It operates through four segments: Aluminium, Alumina, Energy, and Mining and Metals. The company is involved in the mining and refining of bauxite and nepheline ore into alumina; the smelting of primary aluminum from alumina; and the fabrication of aluminum and aluminum alloys into semi-fabricated and finished products. Its products include primary aluminum, billets, rolling slabs, primary foundry alloys, wire rods, high-purity aluminum, foil and packaging products, aluminum wheels and powders, alumina and bauxite products, corundum products, and gallium and silicon products, as well as aluminum anodes for cathodic protection. The company is also involved in the mining and sale of coal; generation and transmission of electricity produced from various sources; and trading businesses. In addition, it offers repair and maintenance, and finance services. The company sells its products primarily in Europe, Russia, other countries of the Commonwealth of Independent States, Asia, and North and South America. The company was founded in 2000 and is based in Kaliningrad, Russia. United Company RUSAL, International Public Joint-Stock Company is a subsidiary of En+ GROUP International public joint-stock company.
Full UNRIF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.